Rule 8.3-Claimar Care Group
11 Août 2009 - 10:59AM
UK Regulatory
TIDMCCGP
RNS Number : 2324X
Charles Stanley & Co. Ltd.
11 August 2009
FORM 8.3
DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE
(Rule 8.3 of the City Code on Takeovers and Mergers)
1.KEY INFORMATION
+------------------------------------+------------------------------------------------------+
| Name of person dealing (Note 1) | Charles Stanley & Co Ltd |
+------------------------------------+------------------------------------------------------+
| Company dealt in | Claimar Care Group Plc |
+------------------------------------+------------------------------------------------------+
| Class of relevant security to | Ordinary |
| which the dealings being disclosed | |
| relate (Note 2) | |
+------------------------------------+------------------------------------------------------+
| Date of dealing | 10 August 2009 |
+------------------------------------+------------------------------------------------------+
2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE
(a)Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
+------------------------------------+---------------------------+---------------------------+
| | Long | Short |
+------------------------------------+---------------------------+---------------------------+
| | Number | Number |
| | (%) | (%) |
+------------------------------------+---------------------------+---------------------------+
| (1) Relevant securities | 680,1661.36% | |
| | | |
+------------------------------------+---------------------------+---------------------------+
| (2) Derivatives (other than | | |
| options) | | |
| | | |
+------------------------------------+---------------------------+---------------------------+
| (3) Options and agreements to | | |
| purchase/sell | | |
| | | |
+------------------------------------+---------------------------+---------------------------+
| Total | 680,1661.36% | |
| | | |
+------------------------------------+---------------------------+---------------------------+
(b)Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
+------------------------------------+--------------------------+----------------------------+
| Class of relevant security: | Long | Short |
| | | |
+------------------------------------+--------------------------+----------------------------+
| | Number | Number |
| | (%) | (%) |
+------------------------------------+--------------------------+----------------------------+
| (1) Relevant securities | | |
| | | |
+------------------------------------+--------------------------+----------------------------+
| (2) Derivatives (other than | | |
| options) | | |
| | | |
+------------------------------------+--------------------------+----------------------------+
| (3) Options and agreements to | | |
| purchase/sell | | |
| | | |
+------------------------------------+--------------------------+----------------------------+
| Total | | |
| | | |
+------------------------------------+--------------------------+----------------------------+
(c) Rights to subscribe (Note 3)
+------------------------------------+------------------------------------------------------+
| Class of relevant security: | Details |
| | |
+------------------------------------+------------------------------------------------------+
| | |
+------------------------------------+------------------------------------------------------+
3. DEALINGS (Note 4)
(a)Purchases and sales
+------------------------------+-----------------------------+-------------------------------+
| Purchase/sale | Number of securities | Price per unit (Note 5) |
| | | |
+------------------------------+-----------------------------+-------------------------------+
| Purchase | 15,000 | GBP0.32 GBP |
| | | |
+------------------------------+-----------------------------+-------------------------------+
(b) Derivatives transactions (other than options)
+-----------------+--------------------+----------------------------+-------------------------+
| Product name, | Long/short (Note | Number of securities (Note | Price per unit (Note 5) |
| e.g. CFD | 6) | 7) | |
+-----------------+--------------------+----------------------------+-------------------------+
| | | | |
+-----------------+--------------------+----------------------------+-------------------------+
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
+-----------------+--------------+-----------------+----------+------------+---------+---------------+
| Product name, | Writing, | Number of | Exercise | Type, e.g. | Expiry | Option money |
| e.g. call | selling, | securities to | price | American, | date | paid/received |
| option | purchasing, | which the | | European | | per unit |
| | varying etc. | option relates | | etc. | | (Note 5) |
| | | (Note 7) | | | | |
+-----------------+--------------+-----------------+----------+------------+---------+---------------+
| | | | | | | |
+-----------------+--------------+-----------------+----------+------------+---------+---------------+
(ii) Exercising
+------------------------------+-----------------------------+-------------------------------+
| Product name, e.g. call | Number of securities | Exercise price per unit (Note |
| option | | 5) |
| | | |
+------------------------------+-----------------------------+-------------------------------+
| | | |
+------------------------------+-----------------------------+-------------------------------+
(d) Other dealings (including new securities) (Note 4)
+------------------------------+-----------------------------+-------------------------------+
| Nature of transaction (Note | Details | Price per unit (if |
| 8) | | applicable) (Note 5) |
| | | |
+------------------------------+-----------------------------+-------------------------------+
| | | |
+------------------------------+-----------------------------+-------------------------------+
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
+------------------------------------------------------------------------------------------+
| Full details of any agreement, arrangement or understanding between the person |
| disclosing and any other person relating to the voting rights of any relevant securities |
| under any option referred to on this form or relating to the voting rights or future |
| acquisition or disposal of any relevant securities to which any derivative referred to |
| on this form is referenced. If none, this should be stated. |
+------------------------------------------------------------------------------------------+
| |
+------------------------------------------------------------------------------------------+
Is a Supplemental Form 8 attached? (Note 9)NO
+---------------------------------------------------+---------------------------------------+
| Date of disclosure | 11/08/09 |
| | |
+---------------------------------------------------+---------------------------------------+
| Contact name | Kelvin White |
+---------------------------------------------------+---------------------------------------+
| Telephone number | 0207 149 6464 |
+---------------------------------------------------+---------------------------------------+
| If a connected EFM, name of offeree/offeror with | |
| which connected | |
+---------------------------------------------------+---------------------------------------+
| If a connected EFM, state nature of connection | |
| (Note 10) | |
+---------------------------------------------------+---------------------------------------+
Notes
The Notes on Form 8.3 can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
RETCKDKPFBKKFFD
Claimar Care (LSE:CCGP)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Claimar Care (LSE:CCGP)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Claimar Care (London Stock Exchange): 0 recent articles
Plus d'articles sur Claimar Care